Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Patients and data tracking

- PMLiVE

Novartis launches European advanced breast cancer campaign

Campaign launches with audio/visual installation

- PMLiVE

J&J acquires oncology candidate in $1bn Aragon buy

ARN-509 is in phase II development for castration resistant prostate cancer

- PMLiVE

Men’s oesophageal cancer risk “triple that of women”

New data from Cancer Research UK shines slight on 'quiet epidemic'

- PMLiVE

AstraZeneca picks location for global HQ and research base

Decides on the Cambridge Biomedical Campus in UK

PatientsLikeMe signs clinical trial deal with inVentiv Health

Online patient network aims to help the CRO accelerate trial recruitment

- PMLiVE

New data backs J&J’s ibrutinib efficacy in B cell cancers

Phase II results showcased at European Hematology Association meeting

- PMLiVE

Elotuzumab on track for multiple myeloma

BMS and AbbVie present phase II results at European Haematology Association meeting

- PMLiVE

Former Novartis president joins Qu Biologics

Robert Pelzer is appointed board member at immunotherapy specialists

- PMLiVE

Think positive: the rise of ‘smart drugs’

More and more people are turning to nootropics or 'smart drugs' to enhance their cognitive ability. But what do they do, what are the risks and where do the ethical...

- PMLiVE

ABPI appoints new director of comms

Catherine Meaden was previously head of policy and public affairs at the body

- PMLiVE

AstraZeneca and NGM form diabetes/ obesity partnership

Will use MedImmune arm to develop treatments that target gastrointestinal hormones

Novartis building

Jakavi shows long-term survival benefit in myelofibrosis

Trial demonstrates Novartis’ blood cancer drug cut risk of death by half over three years

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links